Macrophage subsets harbouring Leishmania donovani in spleens of infected BALB/c mice: Localization and characterization

Cellular Microbiology

Volumn 2, Issue 5, 2000, Pages 415-430

  Lang, Thierry ^a   Avé, Patrick ^a   Huerre, Michel ^a   Milon, Genevive ^a   Antoine, Jean Claude ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; MACROSIALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL VACUOLE; IMMUNOHISTOLOGY; IMMUNOSTIMULATION; LEISHMANIA DONOVANI; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PARASITE LOCALIZATION; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; SPLEEN; TIME FACTORS; VACUOLES;

ANIMALIA; LEISHMANIA DONOVANI;

EID: 0033788202     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1462-5822.2000.00070.x     Document Type: Article

References (61)

1. The interaction of Leishmania species with macrophages
2. Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis
3. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages
4. H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leismania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana
5. Antigen presentation by epidermal langerhans cells in experimental cutaneous leishmaniasis
6. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues
7. Regulation of activated macrophage antimicrobial activities: Identification of lymphokines that cooperate with IFN-γ for induction of resistance to infection
8. An easily prepared defined medium for cultivation of Leismania donovani promastigotes
9. + T cells
10. A shared alloantigenic determinant on la antigens encoded by the I-A and I-E subregions: Evidence for I region gene duplication
11. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leismania major
12. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leismania donovani in murine resident peritoneal macrophages
13. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody
14. Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the Innate immune response to a protozoan parasite
15. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leismania donovani
16. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in m urine liver
17. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani Infection
18. Kinetics of intracellular transport and sorting of lysosomal membrane and plasma membrane proteins
19. Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis
20. Pathologic changes in murine leishmaniasis (Leismania donovani) with special references to the dynamics of granuloma formation
21. Leishmania major. analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice
22. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets
23. + lymphocytes in rive during healing and progressive murine leishmaniasis
24. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts
25. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis
26. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages
27. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody
28. Cells in the marginal zone of the spleen
29. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody
30. Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An Immunohistochemical study
31. Leishmania donovani-infected macrophages: Characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation
32. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice. A tissue-dependent pattern controlled by the Lsh and MHC loci
33. Glycoproteins of the lysosomal membrane
34. Cutaneous leishmaniasis. The defect in T cells influx in BALB/c mice
35. The dynamics of granuloma formation in experimental visceral leishmaniasis
36. Regional differences in the cellular immune response to experimental cutaneous or visceral leishmaniasis with Leishmania donovani
37. One approach to assess the liver response in murine listeriosis and visceral leishmaniasis
38. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis
39. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen specific-T cell immune response
40. Langerhans cells transport Leismania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells
41. T-cell responses and immunity to experimental infection with Leishmania major
42. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-γ is the activating cytokine
43. Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis
44. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity
45. Clinical spectrum of Leishmaniasis
46. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain
47. Compensation for decreased expression of B7 molecules on Leismania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production
48. Immunocytochemical characterization of the endocytic and phagolysosomal compartments in peritoneal macrophages
49. The regulation of immunity to Leishmania major
50. Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens
51. Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages
52. Macrophage-T cell interaction in experimental visceral leishmaniasis: Failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity
53. Destruction of follicular dendritic cells during chronic visceral leishmaniasis
54. Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes
55. Mac-1: A macrophage differentiation antigen identified by monoclonal antibody
56. Experimental visceral leishmaniasis: Role of endogenous IFN-γ in host defense and tissue granulomatous response
57. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase
58. Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis
59. Limiting dilution assays. Experimental design and statistical analysis
60. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis
61. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues